RxDoctor Payments Data

Kelly Manganello

Physician Assistant · Williamsville, NYNPI 1669638953

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 453 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 34.8% of the total. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,082in general payments, 2019–2025

Across 453 payments — averaging $13.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$839
  • Johnson & Johnson$827
  • Sanofi$475
  • E.r. Squibb & Sons, L.L.C.$340
  • Dermavant Sciences, Inc.$273
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$5,98298%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,082 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Medicare billing

Part B allowed, 2024
$30,450
Medicare patients
157
Services billed
497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab16$61,519
Ketoconazole181$3,966
Fluocinonide86$3,428
Calcipotriene30$3,316
Metronidazole49$2,826
Tacrolimus21$2,550
Clindamycin Phosphate53$2,063
Fluorouracil27$1,998
Triamcinolone Acetonide122$1,708
Clobetasol Propionate51$1,479
Minocycline Hcl72$1,242
Hydrocortisone99$1,148
CiclopiroxCiclopirox Olamine26$947
Ciclopirox20$532
Mycophenolate Mofetil13$502

Paid to pharmacies, not to this prescriber.

Other physician assistant in Williamsville

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →